We found that blocking radiation-induced TGF-β signaling with an ALK5 inhibitor, vactosertib, can suppress radiation-induced oxidative stress generation, fibrosis, and cancer stem cell (CSC) development in breast cancer treatment. This evidence concerns the gene TGFB1 and breast carcinoma.